Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Concurrent thoracic radiotherapy plus chemo-ICI shows no overall survival benefit in ES-SCLC

Dr Bjorn Henning Gronberg - Norwegian University of Science and Technology, Trondheim, Norway
Concurrent thoracic radiotherapy plus chemo-ICI shows no overall survival benefit in ES-SCLC ( Dr Bjorn Henning Gronberg - Norwegian University of Science and Technology, Trondheim, Norway )
10 Jun 2026

1: Safe administration and dosing of EGFR inhibitors in NSCLC - Practical guidance for oncology nurses

Helena Ullgren, Rachel Powell, Irati Rodriguez-Matesanz and Elin Backman Stålnacke
1: Safe administration and dosing of EGFR inhibitors in NSCLC - Practical guidance for oncology nurses ( Helena Ullgren, Rachel Powell, Irati Rodriguez-Matesanz and Elin Backman Stålnacke )
8 Jun 2026

2: Managing EGFR inhibitor side effects in NSCLC - Skin toxicity impact, adherence challenges, and nursing management

Helena Ullgren, Rachel Powell, Patrick Jahn and Elin Backman Stålnacke
2: Managing EGFR inhibitor side effects in NSCLC - Skin toxicity impact, adherence challenges, and nursing management ( Helena Ullgren, Rachel Powell, Patrick Jahn and Elin Backman Stålnacke )
8 Jun 2026

FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in HPV-associated oropharyngeal cancer

Dr Nancy Y. Lee - Memorial Sloan Kettering, New York, USA
FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in HPV-associated oropharyngeal cancer ( Dr Nancy Y. Lee - Memorial Sloan Kettering, New York, USA )
1 Jun 2026

Implanted tile-based radiation shows promise compared with stereotactic radiotherapy for brain metastases

Dr Jeffrey Weinberg - MD Anderson Cancer Center, Houston, USA
Implanted tile-based radiation shows promise compared with stereotactic radiotherapy for brain metastases ( Dr Jeffrey Weinberg - MD Anderson Cancer Center, Houston, USA )
31 May 2026

Neoadjuvant chemoradiotherapy plus sintilimab improves pCR in resectable locally advanced oesophageal squamous cell carcinoma

Dr Xue-Feng Leng - Sichuan Cancer Hospital & Institute, Chengdu, China
Neoadjuvant chemoradiotherapy plus sintilimab improves pCR in resectable locally advanced oesophageal squamous cell carcinoma ( Dr Xue-Feng Leng - Sichuan Cancer Hospital & Institute, Chengdu, China )
30 May 2026

Low-dose CT screening reduces lung cancer mortality and improves survival in broad populations

Dr Caichen Li - Guangzhou Medical University, Guangzhou, China
Low-dose CT screening reduces lung cancer mortality and improves survival in broad populations ( Dr Caichen Li  - Guangzhou Medical University, Guangzhou, China )
13 Apr 2026

Durvalumab after SBRT reduces tumour progression in early-stage NSCLC

Dr Andreas Hallqvist - Sahlgrenska University Hospital, Göteborg, Sweden
Durvalumab after SBRT reduces tumour progression in early-stage NSCLC ( Dr Andreas Hallqvist - Sahlgrenska University Hospital, Göteborg, Sweden )
13 Apr 2026

Cytoreductive SBRT with ipilimumab and nivolumab in de novo mRCC shows no PFS benefit but is safe

Dr Aly-Khan Lalani - McMaster University, Hamilton, Canada
Cytoreductive SBRT with ipilimumab and nivolumab in de novo mRCC shows no PFS benefit but is safe ( Dr Aly-Khan Lalani - McMaster University, Hamilton, Canada )
17 Mar 2026

Transforming radiotherapy skin care by recognising diverse skin reactions

Naman Julka-Anderson - The Royal Marsden NHS Foundation Trust, London, UK
Transforming radiotherapy skin care by recognising diverse skin reactions ( Naman Julka-Anderson - The Royal Marsden NHS Foundation Trust, London, UK )
26 Jan 2026

Improving African representation in breast cancer genomics

Dr Ricardo Pinto - i3S, Porto, Portugal
Improving African representation in breast cancer genomics ( Dr Ricardo Pinto - i3S, Porto, Portugal )
19 Jan 2026

Non-TBI conditioning achieves positive results in MRD-negative CAYA B-ALL undergoing allogeneic HCT

Prof Hisham Abdel-Azim - Loma Linda University, Loma Linda, USA
Non-TBI conditioning achieves positive results in MRD-negative CAYA B-ALL undergoing allogeneic HCT ( Prof Hisham Abdel-Azim - Loma Linda University, Loma Linda, USA )
22 Dec 2025